November 2, 2026

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Innovator with a 166% Potential Upside

Atrium Therapeutics, Inc. (RNA) stands out in the biotechnology sector with its pioneering focus on RNA-based therapies for cardiomyopathies. As a company at the forefront of..

Stevanato Group S.p.A. (STVN) Stock Analysis: Understanding the 28.18% Potential Upside

Investors eyeing opportunities in the healthcare sector may find Stevanato Group S.p.A. (NYSE: STVN) a compelling case for further analysis. With a market capitalization of $5.29..

Globus Medical, Inc. (GMED) Stock Analysis: A 29% Potential Upside Amidst Strong Buy Ratings

Investors eyeing the healthcare sector should pay close attention to Globus Medical, Inc. (NYSE: GMED), a leading player in the medical devices industry. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: A Look at Its 19.86% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been turning heads with its innovative approach to healthcare plans. With a..

Integer Holdings Corporation (ITGR) Stock Analysis: What Investors Need to Know About the Healthcare Giant

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device sector, presents a unique investment opportunity within the healthcare industry. Headquartered in Plano, Texas,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Healthcare Market with a Promising Technology

Inspire Medical Systems, Inc. (NASDAQ: INSP) has carved a niche within the healthcare sector, focusing on innovative solutions for obstructive sleep apnea (OSA), a condition affecting..

Alkermes plc (ALKS) Stock Analysis: Exploring a 24% Upside Potential with Strong Buy Ratings

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company based in Dublin, Ireland, is drawing significant attention from investors, thanks to its robust pipeline and promising growth metrics...

TG Therapeutics, Inc. (TGTX): Investor Outlook on a Booming Biotech with 13.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing the attention of the investment community with its promising outlook and robust performance metrics. As a commercial-stage biopharmaceutical company..

The Ensign Group, Inc. (ENSG) Stock Analysis: Uncovering a 23.18% Potential Upside in Healthcare Investment

The Ensign Group, Inc. (NASDAQ: ENSG) presents a compelling investment opportunity within the healthcare sector, particularly for those eyeing the medical care facilities industry. With a..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotechnology Innovator with 16.20% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a key player in the biotechnology sector, is drawing investor attention with its innovative approach to treating rare diseases and a notable..

Waystar Holding Corp. (WAY) Stock Analysis: Healthcare Innovator with 21.75% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY), with its innovative cloud-based software solutions for healthcare payments, is capturing the attention of investors seeking growth in the healthcare sector...

Revolution Medicines, Inc. (RVMD): Investor Outlook Highlights 35% Potential Upside Amidst Robust Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with a promising 35.30% potential upside, as indicated by the average analyst target price of $258.84 compared..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Investment Landscape with a Potential 9.99% Downside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector and specifically in the medical devices industry, presents a compelling case for investors looking..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 14.12% Potential Upside in the Healthcare Sector

For investors seeking exposure in the healthcare sector, Henry Schein, Inc. (HSIC) presents a compelling opportunity with a potential upside of 14.12%, according to analyst consensus...

Centene Corporation (CNC) Stock Analysis: A Steady Healthcare Player with an 8.84% Potential Upside

Centene Corporation (NYSE: CNC), a notable player in the healthcare sector, operates a comprehensive managed care business catering to under-insured families and commercial organizations across the..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Promising 24% Upside for Investors

Investors with an eye for opportunities in the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing option. As a prominent player in..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Explore a 38.2% Potential Upside with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare industry, offers a compelling case for investors seeking growth in the specialty and generic..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 93% Potential Upside Amid Biotech Innovation

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising RNA-targeted therapies and a substantial..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Unveiling 51.81% Potential Upside Amid Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its innovative approach to treating rare neuroendocrine diseases. With a market capitalization of..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Uncovering a Potential 92.38% Upside

Investors eyeing opportunities in the healthcare sector might find a compelling case in Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biotechnology firm focused on developing novel therapies..

Search

Funds

November 2, 2026

Search

Funds

November 2, 2026

FTSE 100

Funds